Specific tau variants in the brains of patients with myotonic dystrophy

Neurology

Volumn 47, Issue 3, 1996, Pages 711-717

  Vermersch, P ^a   Sergeant, N ^b   Ruchoux, M M ^c   Hofmann Radvanyi, H ^d   Wattez, A ^e   Petit, H ^a   Dewailly, Ph ^a   Delacourte, A ^b  

^a INSERM   (France)

^b Departmentof Pathology   (France)

^c Department of Neurology ^*  (France)

^d UNIV LILLE   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; TAU PROTEIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; ENTORHINAL CORTEX; ENZYME ACTIVITY; GENE MUTATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MYOTONIC DYSTROPHY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPORAL CORTEX;

EID: 0029822936     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.3.711     Document Type: Article

References (51)

1. Harper PS. Myotonie dystrophy. 2nd ed. London: WB Saunders, 1989.
2. Buxton J, Shelbourne P, Davies J, et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992;355:547-548.
3. Fu YH, Pizzuti RG, Fenwick J, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
4. Jansen G, Mahadevan M, Amemiya C, et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet 1992;l:261-266.
5. Harley HG, Brook JD, Rundle SA, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic variation in myotonic dystrophy. Nature 1992;355:545-546.
6. Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol 1995;242:99-104.
7. Bird TD, Follet C, Griep E. Cognitive and personality function in myotonic muscular dystrophy. J Neurol Neurosurg Psychiatry 1983;46:971-980.
8. Chang L, Anderson T, Migneco A, et al. Cerebral abnormalities in myotonic dystrophy: cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol 1993;50:917-923.
9. Rosman NP, Kakulas BA. Mental deficiency associated with muscular dystrophy: a neuropathological study. Brain 1966; 89:769-788.
10. Wisniewski HM, Berry K, Spiro AJ. Ultrastructure of thalamic neuronal inclusions in myotonic dystrophy. J Neurol Sei 1975;24:321-329.
11. Ono S, Inoue K, Mannen T, Kanda F, Jinnai K, Takahashi K Neuropathological changes of the brain in myotonic dystrophy: some new observations. J Neurol Sei 1987;81:301-320.
12. Sarai K, Ishino H, Yoshioka T, Ogura C, Gomyodo M. An autopsy case of myotonic dystrophica. Rinsho Shinkeigaku 1969;9:l-7.
13. Kuroda S, Ihara Y, Namba R. Neurofibrillary changes in the brains of two siblings with myotonic dystrophy. Neuropathology (Tokyo) 1988;9:43-48.
14. Mitake S, Inagaki T, Niimi T, Shirai T, Yamamoto M. Development of Alzheimer neurofibrillary changes in two autopsy cases of myotonic dystrophy. Rinsho Shinkeigaku 1989;29: 488-492.
15. Kiuchi A, Otsuka N, Namba Y, Nakano I, Tomonaga M. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol (Berl) 1991;82:l-5.
16. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubuleassociated protein T (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sei USA 1986;83:4913-4917.
17. Delacourte A, Flament S, Dibe EM, et al. Pathological proteins tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease: demonstration with a panel of antibodies against tau proteins. Acta Neuropathol (Berl) 1990;80:111-117.
18. Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol (Berl) 1994;87:572-577.
19. Delacourte A, Robitaille Y, Sergeant N, et al. Specific pathological tau variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;55:151-159.
20. Matsuo EK, Shin RW, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13:989-1002.
21. Sergeant N, Bussière T, Vermersch P, Lejeune JP, Delacourte A. Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. Neuroreport 1995;6:2217-2220.
22. Reig S, Buée-Scherrer V, Défossez A, Delacourte A, Beauvillain JC, Mazzuca M. Immunogold labeling of paired helical filaments and amyloid filaments by specific monoclonal and polyclonal antibodies. Acta Neuropathol (Berl) 1995;146:924-932.
23. Buée-Scherrer V, Condamines O, Mourton-Gilles C, Jakes R, Goedert M, Pau B, Delacourte A. AD2, a phosphorylationdependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res 1996; 39:79-88.
24. Brodmann K. Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien daigestellt auf Grund des Zellenbaues. Leipzig: JA Barth, 1909.
25. Nieuwenhuys R, Voogd J, Van Huijzen C. The human central nervous system: a synopsis and atlas. 3rd ed rev. New York: Springer-Verlag, 1988.
26. Laemmli UK. Cleavage of structural proteins during head assembly of bacteriophage T4. Nature 1970;227:680-685.
27. O'Farrell P. High-resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-4021.
28. Szendrei GI, Lee VMY, Otvos J Recognition of the minimal epitope of monoclonal antibody tau-1 depends upon the presence of a phosphate group but not its location. J Neurosci Res 1993;34:243-249.
29. Vermersch P, Frigard B, Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol (Berl) 1992;85:48-54.
30. Vermersch P, David JPh, Frigard B, et al. Cortical mapping of brain pathology in brains of aged non-demented subjects. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:1035-1047.
31. Braak H, Braak E, Grundke-Iqbal I, Iqbal K. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 1986;65:351-355.
32. Lee VMY, Balin BJ, Otvos L, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991;251:675-678.
33. Hanger DP, Brion JP, Gallo JM, Cairns NJ, Luthert PJ, Anderton BH. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J 1991;275:99-104.
34. Hof PR, Bierer LM, Perl DP, et al. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Arch Neurol 1992;49:946-953.
35. Delacourte A. Pathological tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration. Biomed Pharniacother 1994;48:287-295.
36. Drewes G, Lichtenberg-Kraag B, Doling F, et al. Mitogen activated protein (MAP) kinase transform tau protein into an Alzheimer state. EMBO J 1992;11:2131-2138.
37. Mandelkow EM, Drewes G, Biernat J, et al. Glycogen synthase kinase 3 and the Alzheimer's disease-like state of microtubule-associated protein tau. FEES Lett 1992;314:315-321.
38. Paudel HK, Lew J, Zenobia A, Wang JH. Brain prolinedirected protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem 1993;268:23512-23518.
39. Ledesma MD, Correas L, Avila J, Diaz-Nido J. Implication of brain cdc2 and MAP kinases in the phosphorylation of tau protein in Alzheimer's disease. FEES Lett 1992;308:218-224.
40. Vulliet R, Halloran SM, Braun RK, Smith AJ, Lee G. Prolinedirected phosphorylation of human tau protein. J Biol Chem 1992;267:22570-22574.
41. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
42. Sabourin LA, Mahadevan MS, Narang M, Lee DSC, Surh LC, Korneluk RG. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nat Genet 1993;4:233-238.
43. Fu YH, Friedman DL, Richards S, et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993;260:235-238.
44. Wang J, Pegoraro E, Menegazzo E, et al. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet 1995;4:599-606.
45. Yamamoto KK, Gonzalez GA, Biggs WH, Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 1988;334:494-498.
46. Foullkes NS, Borrelli E, Sassone-Corsi P. CREM gene: use of alternative DNA binding domains generates multiple antagonists of cAMP-induced transcription. Cell 1991;64:739-749.
47. Shaw DJ, McCurrach M, Rundle SA, et al. Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 1993;18:673-679.
48. Jansen G, Mahadevan M, Amemiya G, et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet 1992;l:261-266.
49. Martin GM. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects 1978;14:5-39.
50. Flament S, Delacourte A, Mann DMA. Phosphorylation of tau proteins: a major event during the process of neurofibrillary degeneration (a comparative study between Alzheimer's disease and Down's syndrome). Brain Res 1990;516:15-19.
51. Kowall NW. Beta amyloid neurotoxicity and neuronal degeneration in Alzheimer's disease. Neurobiol Aging 1994;15:257-258.